Generic Industry Looking For Expanded Inspections As US FDA Rehires Staff

 
• By Grace Moser
  
AAM said FDA inspections have not returned to pre-COVID-19 pandemic levels (Shutterstock)

More from Regulation

More from Policy & Regulation